| Drug Name |
Danazol |
| Drug ID |
BADD_D00576 |
| Description |
A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. |
| Indications and Usage |
For the treatment of endometriosis and fibrocystic breast disease (in patients unresponsive to simple measures). Also used for the prophylactic treatment of all types of hereditary angioedema in males and females. |
| Marketing Status |
approved |
| ATC Code |
G03XA01 |
| DrugBank ID |
DB01406
|
| KEGG ID |
D00289
|
| MeSH ID |
D003613
|
| PubChem ID |
28417
|
| TTD Drug ID |
D09IPV
|
| NDC Product Code |
38779-0174; 0555-0635; 0555-0633; 62135-477; 0527-1369; 71205-862; 0527-1392; 53104-7501; 71052-662; 62135-476; 62135-475; 0527-1368; 49452-2436; 71205-861; 49076-5201; 0555-0634 |
| UNII |
N29QWW3BUO
|
| Synonyms |
Danazol | Danazant | Panacrine | Danocrine | Ladogal | Cyclomen | Danatrol | Danol | Danoval | Norciden | Azol | Danazol-Ratiopharm | Danazol Ratiopharm |
